A Novel Four-Gene Signature Based on Nonsense-Mediated RNA Decay for Predicting Prognosis in Hepatocellular Carcinoma: Bioinformatics Analysis and Functional Validation.

Jiaxin Zhao Cheng WangLiang ZhaoHuiying ZhouRui WuTao ZhangJiawei DingJunjie ZhouHuilin ZhengLei ZhangTianci Kong Jie Zhou Zhenhua Hu

Published in: Journal of hepatocellular carcinoma (2024)

Our NMD-related gene-based risk model can help identify therapeutic targets and biomarkers for HCC. Additionally, it assists clinicians in predicting the prognosis of HCC patients.

Keyphrases

end stage renal disease
bioinformatics analysis
ejection fraction
copy number
genome wide
newly diagnosed
chronic kidney disease
palliative care
genome wide identification
peritoneal dialysis
patient reported outcomes
patient reported
drug induced